Skip to main content
. Author manuscript; available in PMC: 2013 Oct 12.
Published in final edited form as: Leukemia. 2013 May 7;27(10):2062–2066. doi: 10.1038/leu.2013.143

Table 3.

Second malignancies among patient with MM (n=286)

Type of second
malignancy 		After initiation of
lenalidomide 		Before diagnosis
of MM
Skin (BCC/SCC) 9 12
Solid tumor totala 10 37
Prostate 1 16
Breast 2 7
Melanoma 3 1
Other solid tumorsb 4 11
Renal cell cancer 0 2
Hematologic total 2 3
AML 2 0
CLL 0 2
DLBCL 0 1
Total overall 21 52

Abbreviations: AMl, acute myeloid leukemia; BCC, basal cell carcinoma; CLL, chronic lymphoid leukemia; DLBCL, diffuse large B-cell lymphoma; SCC, squamous cell carcinoma.

a

Solid tumor excludes skin cancers (except melanoma) and hematological malignancies.

b

These included: sarcomas, papillary thyroid, nasopharyngeal, head and neck squamous cell carcinoma, hepatocellular carcinoma, carcinoid, testicular cancer and bladder carcinoma.